-       Report 
- October 2025
-  198 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
            -       Report 
- October 2025
-  183 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
            -       Drug Pipelines 
- June 2025
-  150 Pages 
- Global 
   From       €2683EUR$3,000USD£2,360GBP 
      €3354EUR$3,750USD£2,950GBP 
            -       Drug Pipelines 
- April 2025
-  60 Pages 
- Global 
   From       €1431EUR$1,600USD£1,259GBP 
      €1789EUR$2,000USD£1,574GBP 
          -       Report 
- March 2025
-  222 Pages 
- Global 
   From       €2236EUR$2,500USD£1,967GBP 
           -       Report 
- August 2025
-  277 Pages 
- Global 
   From       €3980EUR$4,450USD£3,501GBP 
          -       Report 
- July 2025
-  350 Pages 
- Global 
   From       €4427EUR$4,949USD£3,894GBP 
            -       Report 
- November 2024
-  600 Pages 
- Global 
   From       €2361EUR$2,640USD£2,077GBP 
      €2952EUR$3,300USD£2,596GBP 
            -       Report 
- August 2025
-  185 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
            -       Report 
- August 2025
-  195 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
            -       Report 
- August 2025
-  196 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
          -       Report 
- June 2025
-  193 Pages 
- Global 
   From       €4025EUR$4,500USD£3,541GBP 
          -       Report 
- October 2025
-  384 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
          -       Report 
- October 2025
-  382 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
          -       Report 
- October 2025
-  250 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- March 2025
-  200 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
            -       Drug Pipelines 
- April 2025
-  40 Pages 
- Global 
   From       €894EUR$1,000USD£787GBP 
      €1118EUR$1,250USD£983GBP 
            -       Drug Pipelines 
- April 2025
-  60 Pages 
- Global 
   From       €1431EUR$1,600USD£1,259GBP 
      €1789EUR$2,000USD£1,574GBP 
            -       Drug Pipelines 
- April 2025
-  60 Pages 
- Global 
   From       €1431EUR$1,600USD£1,259GBP 
      €1789EUR$2,000USD£1,574GBP 
          -       Report 
- November 2024
-  202 Pages 
- Global 
   From       €2236EUR$2,500USD£1,967GBP 
       
       The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy.
The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for    market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less   Read more